Clinical Trial

A Comparative Study Between Laryseal Pro Extraglottic Device and Ambu Aura Gain Laryngeal Mask as a Conduit for Fiberoptic Tracheal Intubation in Pediatric Population

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 25, 2025 (before its estimated December 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study aims to compare between Laryseal Pro and Ambu Aura Gain extraglottic devices as conduits for fiberoptic endotracheal intubation regarding time of endotracheal intubation in pediatric population.
Trial Details
NCT Number NCT06945029
Lead Sponsor Cairo University
Conditions Laryseal Pro and Ambu Aura Gain as Conduits for Fiberoptic Endotracheal Intubation
Enrollment 100 participants
Start Date 2025-04-15
Primary Completion 2025-12-01 (estimated)
Study Completion 2026-04-01 (estimated)
Updated on ClinicalTrials.gov 2025-04-25